{
    "nctId": "NCT01823107",
    "briefTitle": "Feasibility Study of Meso BioMatrix Device for Breast Reconstruction",
    "officialTitle": "Meso BioMatrix Acellular Peritoneum Matrix Breast Reconstruction Feasibility Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 25,
    "primaryOutcomeMeasure": "Rate of Breast Related Adverse Events",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Non-smoker\n* Undergoing unilateral or bilateral, two-stage, tissue expander-assisted breast reconstruction\n* Life expectancy greater than 18 months\n* Agreement to return for the trial required follow-up visits\n\nExclusion Criteria:\n\n* Body mass index \u2265 35\n* Prior reconstructive breast surgery, breast augmentation, mastopexy or reduction mammoplasty\n* History of chronic corticosteroid use\n* Type I Diabetes\n* History of radiation therapy to the chest\n* Pre-operative treatment with induction chemotherapy for breast cancer\n* Pregnancy\n* Participating in another investigational drug or device trial that has not completed the follow-up period",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}